Oversight Watch is The Investigative Journal’s weekly digest of Inspector General reports, False Claims Act enforcement, and whistleblower developments. Every item below is drawn from public records linked in the text.
Washington’s fraud-recovery machinery had one of its busiest weeks of the year. Between August 24 and August 26, the Justice Department announced five False Claims Act resolutions worth a combined total of more than $626 million — led by a $541.5 million settlement with The Villages Health System — while the Justice Department’s Office of the Inspector General (OIG) released an audit documenting contract-administration failures at the Drug Enforcement Administration and misconduct findings involving a former senior FBI official. Whistleblowers were central to much of the week’s activity: court records cited in the settlements indicate relators will collect more than $16 million in statutory shares.
The Villages Health: a $541.5 million Medicare Advantage settlement — and a milestone for self-disclosure
The largest item of the week came Wednesday, when DOJ announced that The Villages Health System LLC (TVH), a provider group headquartered in the Florida retirement community of The Villages, agreed to a $541.5 million settlement resolving allegations that it caused the submission of false diagnosis codes that inflated Medicare Advantage payments from 2020 through 2024. According to the release, the diagnosis codes lacked adequate support in patients’ medical records or rested on improper record amendments, inflating the capitated payments CMS made to three Medicare Advantage organizations — Humana, UnitedHealthcare entities, and GuideWell/Florida Blue — which in turn inflated payments to TVH.
What distinguishes this case is how it began: filings indicate TVH disclosed the conduct itself on December 27, 2024, through HHS-OIG’s Health Care Fraud Self-Disclosure Protocol, and the government expressly credited the company’s cooperation and remediation. TVH filed for Chapter 11 bankruptcy in July 2025, and the bankruptcy court approved the settlement on August 25. Per the release, the three insurers are separately returning overpayments by deleting invalid codes or entering repayment agreements with DOJ and CMS.
The significance is hard to overstate. Assistant Attorney General Brett A. Shumate said the department will “hold accountable entities that inflate payments through invalid diagnoses” while continuing “to credit organizations that disclose wrongdoing.” A half-billion-dollar resolution that originated in a self-disclosure — not a whistleblower complaint or government audit — suggests risk-adjustment coding liability in Medicare Advantage has grown large enough that providers are choosing to come forward before someone else does. DOJ notes the claims are allegations only, with no determination of liability.
Tetra Tech: $57 million for falsified radiation testing at Hunters Point, with $11.97 million to whistleblowers
On Monday, DOJ announced that Tetra Tech EC Inc. paid $57 million to resolve allegations that it fabricated work and falsified data the Navy relied on to determine whether the former Hunters Point Naval Shipyard in San Francisco was free of harmful radiation. The government alleged that under contracts issued between 2003 and 2014, the company instructed field technicians to discard soil samples from potentially contaminated locations and substitute “clean” soil for laboratory analysis, and that it manipulated scan results in its database — collecting unearned award fees and avoiding additional remediation costs.
The consolidated qui tam cases, United States ex rel. Jahr, et al. v. Tetra Tech EC, Inc. (N.D. Cal.), were brought by seven former employees and contractors, whose collective relators’ share is approximately $11,970,000. The settlement follows a separate $40 million recovery under the Superfund law entered in July 2025, according to the release.
The case — first filed in 2013 — illustrates how long environmental-fraud qui tams can take to resolve, and what is at stake when remediation data underpins the transfer of federal land for civilian redevelopment. The claims resolved are allegations only; there has been no determination of liability.
Deloitte: $21.5 million and a new frontier for FCA enforcement
On Tuesday, DOJ announced a $21.5 million settlement with Deloitte entities under the department’s Civil Rights Fraud Initiative, launched in May 2025. The government alleged that from 2017 onward, Deloitte falsely certified compliance with anti-discrimination conditions in federal contracts while operating race- and sex-based workforce composition goals — including, per the release, monthly demographic tracking dashboards, promotion-class targets, and a two-year period in which compensation for roughly 150 senior partners could be affected by demographic goals. “Government contractors cannot reward or penalize employees based on race or sex — and labeling the practice DEI does not make it lawful,” said Attorney General Todd Blanche.
Notably for whistleblower watchers, the qui tam relator here was not an employee but an advocacy organization: the American Alliance for Equal Rights, which filed United States ex rel. American Alliance for Equal Rights v. Deloitte LLP (N.D. Tex.) and will receive $4.3 million under the resolution. The use of the False Claims Act’s qui tam device by mission-driven organizations — rather than insiders — is a development worth tracking, as it may significantly expand who initiates FCA litigation. The claims resolved are allegations only, and there has been no determination of liability.
DermTech: Medicare billed for unreliable skin-cancer tests
Also Wednesday, DOJ announced a settlement with the bankrupt skin-cancer testing company formerly known as DermTech Inc., under which the United States received an allowed unsecured claim of $5,038,011 in the company’s Chapter 11 proceeding. The government alleged that DermTech billed Medicare for melanoma tests run with an unvalidated positive-control range between October 2022 and March 2023, and, between January 2020 and February 2022, for tests lacking sufficient patient RNA that nonetheless generated reported results — and that the company neither retracted results nor adequately refunded Medicare when concerns surfaced.
The underlying qui tam, U.S. ex rel. Luong v. DermTech, Inc. (S.D. Cal.), was filed by a former employee who will receive 20 percent of the bankruptcy recovery. The patient-safety dimension — test results reported to real patients making cancer-screening decisions — distinguishes this case from garden-variety billing fraud. The claims resolved are allegations only.
AiNET: $1.8 million over data-center services billed to the SEC
Rounding out the week’s FCA docket, DOJ announced Monday that AiNET Corp. and its former chief executive Deepak Jain agreed to pay $1.8 million to resolve allegations that they knowingly submitted false claims to the U.S. Securities and Exchange Commission for data-center services. The resolution is a reminder that FCA exposure attaches to contractors serving regulatory agencies themselves — not just benefit programs and the Pentagon.
DOJ OIG: DEA paid $20 million on task orders it could not fully account for
On August 20, the Justice Department’s Office of the Inspector General released an audit (Report 26-080) of four task orders totaling $20 million that DEA awarded to Ocean Bay Information and Systems Management, LLC for outreach, logistical, and administrative support to the agency’s Diversion Control Program — the program charged with policing the legal pharmaceutical supply chain. The audit found the contractor generally provided the agreed-upon services, but the OIG could not determine whether contract workers engaged only in allowable diversion-related activities, or whether the services meaningfully contributed to the program at all.
The details are sobering for anyone who follows federal contract administration. The OIG identified more than $2.9 million in potential funds to be put to better use tied to contract workers who did not appear to meet education or experience qualifications for their positions, found travel costs paid without required pre-approvals, and reported that DEA personnel dictated contractor hiring decisions through “meet-and-greets” despite policies prohibiting exactly that. The report attributes these failures in part to a DEA contracting office that was 83 percent understaffed — and notes that many issues reflected the DEA’s departure from corrective actions adopted after three prior OIG reports.
The OIG made 11 recommendations; DEA agreed with all of them and, per the OIG, has already taken corrective action sufficient to close four. The recidivism angle — an agency drifting away from fixes it previously accepted — is precisely the pattern that congressional appropriators and oversight committees should be pressing agencies on.
DOJ OIG: misconduct findings against a former FBI Special Agent in Charge
On August 19, the DOJ OIG posted an investigative summary (Report 26-081) finding that a then-FBI Special Agent in Charge violated Department of Justice and FBI policies governing the acceptance of gifts, as well as FBI policies on the use and handling of firearms. Consistent with OIG practice for investigative summaries, the individual is not named. Gift-acceptance rules exist to insulate senior law-enforcement officials from even the appearance of capture; findings at the Special-Agent-in-Charge level — the FBI’s senior field leadership rank — merit attention regardless of the disposition.
What warrants a closer look
Three threads from this week merit deeper TIJ investigation. First, Medicare Advantage risk-adjustment coding is emerging as the dominant fraud-recovery theater of 2026: the TVH settlement follows Aetna’s $117.7 million resolution in March over unsupported diagnosis codes, and DOJ noted taxpayers pay Medicare Advantage insurers more than $530 billion annually. A mid-year analysis by law firm Gibson Dunn counted more than $1.8 billion in FCA settlements and judgments in the first half of 2026 alone. The open question TIJ intends to pursue: how many other capitated provider groups have quietly entered the HHS-OIG self-disclosure pipeline, and on what terms.
Second, the DEA audit’s finding of an 83 percent understaffed contracting office raises an obvious follow-up: if acquisition oversight is that thin at one DOJ component, records requests may show similar staffing gaps — and similar blended-workforce risks around inherently governmental functions — across other law-enforcement agencies.
Third, the structural independence of the IG community remains an active storyline. Legislation reported by Government Executive would restructure the inspectors general’s central council, while a separate Senate bill would restrict who may serve as an IG; Senator Chuck Grassley’s bipartisan bills expanding whistleblower protections for “duty speech” and government-corporation employees remain pending. How these proposals fare will shape the oversight pipeline that produced every item in this digest.
Editorial note: This digest is compiled from public records — DOJ press releases, OIG reports, and congressional documents — linked throughout. Settlement claims described above are allegations only; no court has made a determination of liability, and settling parties did not admit wrongdoing in the agreements cited. The companies and individuals referenced did not provide comment for this digest; TIJ welcomes responses from any party named, which will be published as received.